Eversept Partners, LP Albireo Pharma, Inc. Transaction History

Eversept Partners, LP

  • $1.33 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Nov 08, 2023
BUY
$16.92 - $28.96 $1.02 Million - $1.74 Million
60,000 Added 332.8%
78,029 $1.98 Million
Q4 2019

Feb 13, 2020
BUY
$16.92 - $28.96 $1.02 Million - $1.74 Million
60,000 Added 332.8%
78,029 $1.98 Million
Q1 2018

Nov 08, 2023
BUY
$26.78 - $39.35 $482,816 - $709,441
18,029 New
18,029 $587 Million
Q1 2018

May 14, 2018
BUY
$26.78 - $39.35 $482,816 - $709,441
18,029 New
18,029 $587,000

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email